Synthesis and Characterization of New Porphyrazine-Gd(III) Conjugates as Multimodal MR Contrast Agents
- 9 November 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 21 (12), 2267-2275
- https://doi.org/10.1021/bc1002828
Abstract
Magnetic resonance imaging (MRI) has long been used clinically and experimentally as a diagnostic tool to obtain three-dimensional, high-resolution images of deep tissues. These images are enhanced by the administration of contrast agents such as paramagnetic Gd(III) complexes. Herein, we describe the preparation of a series of multimodal imaging agents in which paramagnetic Gd(III) complexes are conjugated to a fluorescent tetrapyrrole, namely, a porphyrazine (pz). Zinc metalated pzs conjugated to one, four, or eight paramagnetic Gd(III) complexes are reported. Among these conjugates, Zn-Pz-8Gd(III) exhibits an ionic relaxivity four times that of the monomeric Gd(III) agent, presumably because of increased molecular weight and a molecular relaxivity that is approximately thirty times larger, while retaining the intense electronic absorption and emission of the unmodified pz. Unlike current clinical MR agents, Zn-Pz-1Gd(III) is taken up by cells. This probe demonstrates intracellular fluorescence by confocal microscopy and provides significant contrast enhancement in MR images, as well as marked phototoxicity in assays of cellular viability. These results suggest that pz agents possess a new potential for use in cancer imaging by both MRI and near-infrared (NIR) fluorescence, while acting as a platform for photodynamic therapy.Keywords
This publication has 32 references indexed in Scilit:
- Chiral bis‐Acetal Porphyrazines as Near‐infrared Optical Agents for Detection and Treatment of CancerPhotochemistry and Photobiology, 2010
- Chiral porphyrazine near-IR optical imaging agent exhibiting preferential tumor accumulationProceedings of the National Academy of Sciences of the United States of America, 2009
- Synthesis of Multimeric MR Contrast Agents for Cellular ImagingJournal of the American Chemical Society, 2008
- High Relaxivity Gadolinium Hydroxypyridonate−Viral Capsid Conjugates: Nanosized MRI Contrast Agents1Journal of the American Chemical Society, 2008
- Polymer platforms for drug delivery and biomedical imagingJournal of Controlled Release, 2007
- Multimodal MRI contrast agentsJBIC Journal of Biological Inorganic Chemistry, 2007
- Synthesis and Characterization of HE-24.8: A Polymeric Contrast Agent for Magnetic Resonance AngiographyBioconjugate Chemistry, 2005
- Development of Magnetic Resonance Imaging Contrast Material for In vivo Mapping of Tissue Transglutaminase ActivityCancer Research, 2005
- Cellular Delivery of MRI Contrast AgentsCell Chemical Biology, 2004
- Peripherally Functionalized Porphyrazines: Novel Metallomacrocycles with Broad, Untapped PotentialPublished by Wiley ,2001